BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration

Blood

Volumn 96, Issue 13, 2000, Pages 4328-4334

  Aguiar, Ricardo C T ^b   Yakushijin, Yoshihiro ^b   Kharbanda, Samir ^b   Salgia, Ravi ^b   Fletcher, Jonathan A ^b   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BAL PROTEIN, HUMAN; HYBRID PROTEIN; RECOMBINANT PROTEIN; STROMAL CELL DERIVED FACTOR 1; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL MOTION; COMPARATIVE STUDY; DRUG EFFECT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LARGE CELL LYMPHOMA; MOLECULAR CLONING; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PATHOLOGY; PHYSIOLOGY; RISK; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES, CXC; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LOW-GRADE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; RISK; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034672418     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4328.h8004328_4328_4334     Document Type: Article

References (15)

1. Shipp M, Harris N, Mauch P. The non-Hodgkin's lymphomas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles & Practices of Oncology. Philadelphia, PA: J.B. Lippincott; 1997:2165-2220.
2. Shipp M, Harrington D, Chairpersons, Anderson J, Armitage J, Bonadonna G, et al. A predictive model for aggressive non-Hodgkin's lymphoma: the International NHL Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
3. Kuppers R, Klein U, Hansmann M-L, Rajewsky K. Cellular origin or human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
4. Drillenburg P, Pals S. Cell adhesion receptors in lymphoma dissemination. Blood. 2000;95:1900-1910.
5. Cyster J. Chemokines and ceil migration in secondary lymphoid organs. Science. 1999;286:2098-2102.
6. Bleul C, Schultze J, Springer T. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med. 1998;187:753-762.
7. Allzadeh A, Elsen M, Davis R, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;4051:503-511.
8. Kulidjian A, Inman R, Issekutz T. Rodent models of lymphocyte migration. Sem in Immunol. 1999;11:85-93.
9. Lauffenburger D, Horwitz A. Cell migration: a physically integrated molecular process. Cell. 1996;84:359-369.
10. Tsuzuki S, Toyama-Sorimachi N, Kitamura F, et al. Intracellular signal-transducing elements involved in transendothelial migration of lymphoid cells. Jpn J Cancer Res. 1998;89:571-577.
11. Aguiar R, Yakushijin Y, Kharbanda S, Tiwari S, Freeman G, Shipp M. PTPROt: an alternatively spliced and developmentally regulated B-lym-phoid phosphatase that promotes GO/G1 arrest. Blood. 1999;94:2403-2413.
12. Liang P, Pardee A. Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science. 1992;257:967.
13. Xiao S, Nalabolu S, Aster J, et al. FGFR1 is fused with a novel zinc-finger gene, 2NF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Gen. 1998;18:84-87.
14. Aguiar R, Sohal J, Van Rhee F, et al. TEL-AML1 fusion in acute lymphoblastic leukemia of adults. Br J Haematol. 1996;95:673-677.
15. Duan D. Humphrey J, Chen D, et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA. 1995;92:6459-6463.